Moderate riskFDA DeviceClass II

Aniara 5-PLASMA Bivalirudin Control recalled for stability issues

Aniara Diagnostica LLC is recalling 9 units of its 5-PLASMA Bivalirudin Control, model 5D-44905, lot KE132602. The agency reports stability issues with the reconstituted plasma and bivalirudin matrix, which degrade measurable bivalirudin in the controls, calibrators and linearity values. The product was distributed in the US in IL, NC and TN.

From the FDA notice · Read the official notice ↗

What to do

  1. Set aside lot KE132602 and do not use it for testing or calibration.
  2. Confirm the product by checking model 5D-44905 and UDI-DI 05070002420385 on the label.
  3. The notice does not state a remedy; contact Aniara Diagnostica LLC for next steps.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
5-PLASMA Bivalirudin Control, Model Number 5D-44905
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
9 units
Illnesses reported
None reported
Manufactured in
7768 Service Center Dr, West Chester, OH, United States
Classification
Class II
Recall number
Z-2896-2026

In the FDA's words

Description
5-PLASMA Bivalirudin Control, Model Number 5D-44905 Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values. UDI-DI: 05070002420385, Lot Number: KE132602 Distribution: US Nationwide distribution in the states of IL, NC, TN. Affected quantity: 9 units
Hazard
Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

3 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics